Key result
The efficacy of emergency TAVR combined with PCI for patients with acute myocardial infarction, severe aortic stenosis, and cardiogenic shock remains an explorable subject.
Why the study?
Acute myocardial infarction is a contraindication to TAVR, and the efficacy of emergency TAVR combined with PCI in patients with acute myocardial infarction, severe aortic stenosis, and cardiogenic shock remains an explorable subject.
Does emergency TAVR combined with PCI improve outcomes in patients presenting with acute myocardial infarction, severe aortic stenosis, and cardiogenic shock?
Does emergency TAVR combined with PCI improve outcomes in patients presenting with acute myocardial infarction, severe aortic stenosis, and cardiogenic shock?
The efficacy of emergency TAVR combined with PCI for patients with acute myocardial infarction, severe aortic stenosis, and cardiogenic shock remains an area requiring further exploration.
Answers are grounded in this paper and cite their sources.
Emergency TAVR+PCI should not yet be routine for AMI with severe AS and shock; leaves open its efficacy pending dedicated trials.
Transcatheter aortic valve replacement (TAVR) is a viable alternative for patients with symptomatic severe aortic stenosis. Acute myocardial infarction is a contraindication to TAVR. The efficacy of emergency TAVR combined with percutaneous coronary intervention for patients presenting with acute myocardial infarction, severe aortic stenosis, and cardiogenic shock remains an explorable subject.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) studied Acute myocardial infarction, severe aortic stenosis, and cardiogenic shock. Emergency TAVR combined with PCI was evaluated. The efficacy of emergency TAVR combined with PCI for patients with acute myocardial infarction, severe aortic stenosis, and cardiogenic shock remains an explorable subject.
Synapse has enriched 10 related papers. Consider them for comparative context: